Health
Form Health Simplifies GLP-1 Coverage Opportunities for Employers with Transparent, Predictable Pricing
BOSTON, December 16, 2025--Today, Form Health, the national leader in science-based obesity and cardiometabolic care, announced access to new programs that provide employers with transparent, predictable access to obesity management medications from Eli Lilly and Company (Lilly) and Novo Nordisk (Novo), helping organizations offer comprehensive, wraparound care while controlling costs.
About this update from Novo Nordisk A/s Class B
[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":782,"height":271,"url":"https://media.zenfs.com/en/business-wire.com/5cdd0cdeae8b7ecf7c57172b8aae2904"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/1gMqxiHFK.2sQx8XWO.6Eg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTMzMztjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/5cdd0cdeae8b7ecf7c57172b8aae2904","width":782,"height":271},"resize_sm":{"url":"https://s.yimg.com/ny/api/res/1.2/cIKnDVdfmQ_yh4ZurC_cPw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTY0MDtoPTIyMjtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/5cdd0cdeae8b7ecf7c57172b8aae2904","width":640,"height":222},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/UrlMvONz36qpUG77Z93esA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTE1NjQ7aD01NDI7Y2Y9d2VicA--/https://media.zenfs.com/en/business-wire.com/5cdd0cdeae8b7ecf7c57172b8aae2904","width":782,"height":271}},"lazy":false},{"type":"text","content":"Form Is Removing Uncertainty From GLP-1 Coverage, Helping Employers Manage Medication Costs While Supporting Employee Health","length":124,"tagName":"p","attribs":{}},{"type":"text","content":"BOSTON, December 16, 2025--(BUSINESS WIRE)--Today, Form Health, the national leader in science-based obesity and cardiometabolic care, announced access to new programs that provide employers with transparent, predictable access to obesity management medications from Eli Lilly and Company (Lilly) and Novo Nordisk (Novo), helping organizations offer comprehensive, wraparound care while controlling costs.","length":405,"tagName":"p"},{"type":"text","content":"This builds on Form’s work with both companies. Form was one of the first telemedicine obesity care providers included on Lilly’s digital healthcare platform, LillyDirect™, and was among the first selected for Novo’s NovoCare® platform earlier this year.","length":254,"tagName":"p"},{"type":"text","content":"Despite increasing awareness of the benefits of GLP-1 therapies, only 19% of companies with 200 or more workers currently cover these medications for weight loss, rising to just 43% among firms with 5,000 or more employees. In addition, 70% of employers cite cost unpredictability and market complexities as a reason not to consider adding GLP-1 coverage.","length":355,"tagName":"p"},{"type":"text","content":"This employer-direct...